David Spetzler MS, MBA, PhD

David Spetzler, MS, MBA, PhD Senior Vice President and Chief Scientific Officer. Dr. Spetzler joined the Caris scientific team in August of 2009, where he currently leads the Research and Development division of Caris. His executive and scientific oversight of the R&D team is focused on the development of clinical assays to aid in the creation of precision medicine strategies for individual cancer patients, as well as noninvasive technologies to identify and predict early stage cancer.

His work is focused on the development of the Caris TOP® technology, a groundbreaking and proprietary method of profiling macro-molecular complexes in their native form in a highly multiplexed format. The innovative technology is the result of the convergence of Caris' deep expertise in nexgen sequencing, exosome biology, bioinformatics, and broad-based molecular profiling.